Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Active Antiretroviral Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00001688
What this trial is testing

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT00130273
What this trial is testing

Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV

Who this might be right for
HIV Infections
University of Pennsylvania 180
Large-scale testing (Phase 3)WithdrawnNCT02069834
What this trial is testing

Dolutegravir + Rilpivirine Switch Study (DORISS)

Who this might be right for
HIV InfectionHAART-treatedVirologically Controlled
Nantes University Hospital
Post-approval studies (Phase 4)Study completedNCT00107887
What this trial is testing

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Who this might be right for
TuberculosisHIV Infections
Johns Hopkins University 17,415
Testing effectiveness (Phase 2)Study completedNCT00795444
What this trial is testing

Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1

Who this might be right for
HIV-1
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Post-approval studies (Phase 4)UnknownNCT01049685
What this trial is testing

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

Who this might be right for
HIV Infections
UPECLIN HC FM Botucatu Unesp 36
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Not applicableStudy completedNCT00168233
What this trial is testing

Impact of HIV and Its Treatment on Reverse Cholesterol Transport

Who this might be right for
HIV Infections
The Alfred 44
Testing effectiveness (Phase 2)Study completedNCT00122538
What this trial is testing

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Who this might be right for
HIV InfectionsAIDS
French National Agency for Research on AIDS and Viral Hepatitis 52
Testing effectiveness (Phase 2)Study completedNCT00109746
What this trial is testing

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

Who this might be right for
Insulin ResistanceHIV Infections
National Center for Complementary and Integrative Health (NCCIH) 39
Not applicableUnknownNCT00974454
What this trial is testing

Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
Acquired Immune Deficiency Syndrome VirusHIV Infections
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 180
Not applicableStudy completedNCT00253682
What this trial is testing

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis+2 more
University of Miami 167
Not applicableStudy completedNCT01488942
What this trial is testing

Use of Incentives to Retain Drug Users in HIV Therapy

Who this might be right for
HIV Infection
University of British Columbia 139
Not applicableStudy completedNCT01236235
What this trial is testing

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Who this might be right for
HIV
Bristol-Myers Squibb 525
Early research (Phase 1)Study completedNCT00879047
What this trial is testing

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Who this might be right for
HIV InfectionsHepatitis C
University of California, San Francisco 30
Not applicableStudy completedNCT00746473
What this trial is testing

Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART

Who this might be right for
HIV Infections
UPECLIN HC FM Botucatu Unesp 73
Not applicableLooking for participantsNCT04160455
What this trial is testing

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Who this might be right for
AutophagyGalectinsHIV Infections+1 more
Centre Hospitalier Régional d'Orléans 180
Testing effectiveness (Phase 2)Study completedNCT00298350
What this trial is testing

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Who this might be right for
HIVHIV-1Human Immunodeficiency Virus
Gilead Sciences 278
Post-approval studies (Phase 4)Study completedNCT01086878
What this trial is testing

Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

Who this might be right for
Acquired Immunodeficiency SyndromeInfant, NewbornAnemia+2 more
Harvard School of Public Health (HSPH) 222
Not applicableStudy completedNCT02711293
What this trial is testing

The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression

Who this might be right for
HIVCommunity Health WorkersAntiretroviral Therapy, Highly Active
Harvard School of Public Health (HSPH) 2,172
Next Page